Global Specialty Enzymes Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	174 Pages	TechNavio	January, 2024	INF18512794

Best Price Guarantee
Price	from $2,500
Length	174 Pages
Publisher	TechNavio
Published Date	January, 2024
SKU	INF18512794

Global Specialty Enzymes Market 2024-2028

The specialty enzymes market is forecasted to grow by USD 1.74 bn during 2023-2028, accelerating at a CAGR of 6.71% during the forecast period. The report on the specialty enzymes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing healthcare expenditure, novel applications of specialty enzymes in pharmaceutical segment, and increased production of biofuels.

Technavio's specialty enzymes market is segmented as below:

By Application

Research and biotechnology
Diagnostic
Others

By Type

Carbohydrases
Proteases
Catalase and others

By Geographical Landscape

North America
Europe
APAC
Middle East and Africa
South America

This study identifies the recent advances in enzyme technology as one of the prime reasons driving the specialty enzymes market growth during the next few years. Also, advances in protein engineering and directed evolution and growing adoption of enzymes for sustainability in industrial processes will lead to sizable demand in the market.

The report on the specialty enzymes market covers the following areas:

Specialty enzymes market sizing
Specialty enzymes market forecast
Specialty enzymes market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading specialty enzymes market vendors that include Advanced Enzyme Technologies Ltd., Amano Enzyme Inc., Amicogen Co., Ltd., Antozyme Biotech Pvt. Ltd., Avantor Inc., BASF SE, BBI Solutions OEM Ltd., BRAIN Biotech AG, Chr Hansen Holding AS, Codexis Inc., Enzyme Development Corp., Enzyme Supplies Ltd., F. Hoffmann La Roche Ltd., International Flavors and Fragrances Inc., Kerry Group Plc, Koninklijke DSM NV, Maravai LifeSciences Holdings Inc., Nagase and Co. Ltd, Novozymes AS, Sanofi SA, and SternEnzym GmbH and Co. KG. Also, the specialty enzymes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Application; Exhibit 06: Executive Summary - Chart on Market Segmentation by Type; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global specialty enzymes market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global specialty enzymes market 2018 - 2022 ($ billion); 4.2 Application Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion); 4.3 Type Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application: 6.1 Market segments; Exhibit 30: Chart on Application - Market share 2023-2028 (%); Exhibit 31: Data Table on Application - Market share 2023-2028 (%); 6.2 Comparison by Application; Exhibit 32: Chart on Comparison by Application; Exhibit 33: Data Table on Comparison by Application; 6.3 Research and biotechnology - Market size and forecast 2023-2028; Exhibit 34: Chart on Research and biotechnology - Market size and forecast 2023-2028 ($ billion); Exhibit 35: Data Table on Research and biotechnology - Market size and forecast 2023-2028 ($ billion); Exhibit 36: Chart on Research and biotechnology - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Research and biotechnology - Year-over-year growth 2023-2028 (%); 6.4 Diagnostic - Market size and forecast 2023-2028; Exhibit 38: Chart on Diagnostic - Market size and forecast 2023-2028 ($ billion); Exhibit 39: Data Table on Diagnostic - Market size and forecast 2023-2028 ($ billion); Exhibit 40: Chart on Diagnostic - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Diagnostic - Year-over-year growth 2023-2028 (%); 6.5 Others - Market size and forecast 2023-2028; Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion); Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion); Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Application; Exhibit 46: Market opportunity by Application ($ billion); Exhibit 47: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Type: 7.1 Market segments; Exhibit 48: Chart on Type - Market share 2023-2028 (%); Exhibit 49: Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Exhibit 50: Chart on Comparison by Type; Exhibit 51: Data Table on Comparison by Type; 7.3 Carbohydrases - Market size and forecast 2023-2028; Exhibit 52: Chart on Carbohydrases - Market size and forecast 2023-2028 ($ billion); Exhibit 53: Data Table on Carbohydrases - Market size and forecast 2023-2028 ($ billion); Exhibit 54: Chart on Carbohydrases - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Carbohydrases - Year-over-year growth 2023-2028 (%); 7.4 Proteases - Market size and forecast 2023-2028; Exhibit 56: Chart on Proteases - Market size and forecast 2023-2028 ($ billion); Exhibit 57: Data Table on Proteases - Market size and forecast 2023-2028 ($ billion); Exhibit 58: Chart on Proteases - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Proteases - Year-over-year growth 2023-2028 (%); 7.5 Catalase and others - Market size and forecast 2023-2028; Exhibit 60: Chart on Catalase and others - Market size and forecast 2023-2028 ($ billion); Exhibit 61: Data Table on Catalase and others - Market size and forecast 2023-2028 ($ billion); Exhibit 62: Chart on Catalase and others - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Catalase and others - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Type; Exhibit 64: Market opportunity by Type ($ billion); Exhibit 65: Data Table on Market opportunity by Type ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 69: Chart on Geographic comparison; Exhibit 70: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 APAC - Market size and forecast 2023-2028; Exhibit 79: Chart on APAC - Market size and forecast 2023-2028 ($ billion); Exhibit 80: Data Table on APAC - Market size and forecast 2023-2028 ($ billion); Exhibit 81: Chart on APAC - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on APAC - Year-over-year growth 2023-2028 (%); 9.6 Middle East and Africa - Market size and forecast 2023-2028; Exhibit 83: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ billion); Exhibit 84: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ billion); Exhibit 85: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%); 9.7 South America - Market size and forecast 2023-2028; Exhibit 87: Chart on South America - Market size and forecast 2023-2028 ($ billion); Exhibit 88: Data Table on South America - Market size and forecast 2023-2028 ($ billion); Exhibit 89: Chart on South America - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on South America - Year-over-year growth 2023-2028 (%); 9.8 US - Market size and forecast 2023-2028; Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Germany - Market size and forecast 2023-2028; Exhibit 107: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 108: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 109: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 110: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.13 Market opportunity By Geographical Landscape; Exhibit 111: Market opportunity By Geographical Landscape ($ billion); Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 113: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 114: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 115: Overview on factors of disruption; 11.4 Industry risks; Exhibit 116: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 117: Vendors covered; 12.2 Market positioning of vendors; Exhibit 118: Matrix on vendor position and classification; 12.3 Advanced Enzyme Technologies Ltd.; Exhibit 119: Advanced Enzyme Technologies Ltd. - Overview; Exhibit 120: Advanced Enzyme Technologies Ltd. - Key offerings; 12.4 Amano Enzyme Inc.; Exhibit 121: Amano Enzyme Inc. - Overview; Exhibit 122: Amano Enzyme Inc. - Product / Service; Exhibit 123: Amano Enzyme Inc. - Key offerings; 12.5 Amicogen Co., Ltd.; Exhibit 124: Amicogen Co., Ltd. - Overview; Exhibit 125: Amicogen Co., Ltd. - Key offerings; 12.6 Antozyme Biotech Pvt. Ltd.; Exhibit 126: Antozyme Biotech Pvt. Ltd. - Overview; Exhibit 127: Antozyme Biotech Pvt. Ltd. - Product / Service; Exhibit 128: Antozyme Biotech Pvt. Ltd. - Key offerings; 12.7 BASF SE; Exhibit 129: BASF SE - Overview; Exhibit 130: BASF SE - Business segments; Exhibit 131: BASF SE - Key news; Exhibit 132: BASF SE - Key offerings; Exhibit 133: BASF SE - Segment focus; 12.8 BBI Solutions OEM Ltd.; Exhibit 134: BBI Solutions OEM Ltd. - Overview; Exhibit 135: BBI Solutions OEM Ltd. - Product / Service; Exhibit 136: BBI Solutions OEM Ltd. - Key offerings; 12.9 BRAIN Biotech AG; Exhibit 137: BRAIN Biotech AG - Overview; Exhibit 138: BRAIN Biotech AG - Product / Service; Exhibit 139: BRAIN Biotech AG - Key offerings; 12.10 Chr Hansen Holding AS; Exhibit 140: Chr Hansen Holding AS - Overview; Exhibit 141: Chr Hansen Holding AS - Business segments; Exhibit 142: Chr Hansen Holding AS - Key news; Exhibit 143: Chr Hansen Holding AS - Key offerings; Exhibit 144: Chr Hansen Holding AS - Segment focus; 12.11 Codexis Inc.; Exhibit 145: Codexis Inc. - Overview; Exhibit 146: Codexis Inc. - Business segments; Exhibit 147: Codexis Inc. - Key offerings; Exhibit 148: Codexis Inc. - Segment focus; 12.12 Enzyme Development Corp.; Exhibit 149: Enzyme Development Corp. - Overview; Exhibit 150: Enzyme Development Corp. - Product / Service; Exhibit 151: Enzyme Development Corp. - Key offerings; 12.13 F. Hoffmann La Roche Ltd.; Exhibit 152: F. Hoffmann La Roche Ltd. - Overview; Exhibit 153: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 154: F. Hoffmann La Roche Ltd. - Key news; Exhibit 155: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 156: F. Hoffmann La Roche Ltd. - Segment focus; 12.14 Koninklijke DSM NV; Exhibit 157: Koninklijke DSM NV - Overview; Exhibit 158: Koninklijke DSM NV - Business segments; Exhibit 159: Koninklijke DSM NV - Key news; Exhibit 160: Koninklijke DSM NV - Key offerings; Exhibit 161: Koninklijke DSM NV - Segment focus; 12.15 Maravai LifeSciences Holdings Inc.; Exhibit 162: Maravai LifeSciences Holdings Inc. - Overview; Exhibit 163: Maravai LifeSciences Holdings Inc. - Business segments; Exhibit 164: Maravai LifeSciences Holdings Inc. - Key offerings; Exhibit 165: Maravai LifeSciences Holdings Inc. - Segment focus; 12.16 Novozymes AS; Exhibit 166: Novozymes AS - Overview; Exhibit 167: Novozymes AS - Business segments; Exhibit 168: Novozymes AS - Key news; Exhibit 169: Novozymes AS - Key offerings; Exhibit 170: Novozymes AS - Segment focus; 12.17 Sanofi SA; Exhibit 171: Sanofi SA - Overview; Exhibit 172: Sanofi SA - Business segments; Exhibit 173: Sanofi SA - Key news; Exhibit 174: Sanofi SA - Key offerings; Exhibit 175: Sanofi SA - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 176: Inclusions checklist; Exhibit 177: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 178: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 179: Research methodology; Exhibit 180: Validation techniques employed for market sizing; Exhibit 181: Information sources; 13.5 List of abbreviations; Exhibit 182: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global specialty enzymes market 2018 - 2022 ($ billion); Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion); Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Application - Market share 2023-2028 (%); Exhibits31: Data Table on Application - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Application; Exhibits33: Data Table on Comparison by Application; Exhibits34: Chart on Research and biotechnology - Market size and forecast 2023-2028 ($ billion); Exhibits35: Data Table on Research and biotechnology - Market size and forecast 2023-2028 ($ billion); Exhibits36: Chart on Research and biotechnology - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Research and biotechnology - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Diagnostic - Market size and forecast 2023-2028 ($ billion); Exhibits39: Data Table on Diagnostic - Market size and forecast 2023-2028 ($ billion); Exhibits40: Chart on Diagnostic - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Diagnostic - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ billion); Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ billion); Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by Application ($ billion); Exhibits47: Data Table on Market opportunity by Application ($ billion); Exhibits48: Chart on Type - Market share 2023-2028 (%); Exhibits49: Data Table on Type - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Type; Exhibits51: Data Table on Comparison by Type; Exhibits52: Chart on Carbohydrases - Market size and forecast 2023-2028 ($ billion); Exhibits53: Data Table on Carbohydrases - Market size and forecast 2023-2028 ($ billion); Exhibits54: Chart on Carbohydrases - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Carbohydrases - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Proteases - Market size and forecast 2023-2028 ($ billion); Exhibits57: Data Table on Proteases - Market size and forecast 2023-2028 ($ billion); Exhibits58: Chart on Proteases - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Proteases - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Catalase and others - Market size and forecast 2023-2028 ($ billion); Exhibits61: Data Table on Catalase and others - Market size and forecast 2023-2028 ($ billion); Exhibits62: Chart on Catalase and others - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Catalase and others - Year-over-year growth 2023-2028 (%); Exhibits64: Market opportunity by Type ($ billion); Exhibits65: Data Table on Market opportunity by Type ($ billion); Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits69: Chart on Geographic comparison; Exhibits70: Data Table on Geographic comparison; Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on APAC - Market size and forecast 2023-2028 ($ billion); Exhibits80: Data Table on APAC - Market size and forecast 2023-2028 ($ billion); Exhibits81: Chart on APAC - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on APAC - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ billion); Exhibits84: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ billion); Exhibits85: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on South America - Market size and forecast 2023-2028 ($ billion); Exhibits88: Data Table on South America - Market size and forecast 2023-2028 ($ billion); Exhibits89: Chart on South America - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on South America - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits107: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits108: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits109: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits110: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits111: Market opportunity By Geographical Landscape ($ billion); Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits113: Impact of drivers and challenges in 2023 and 2028; Exhibits114: Overview on Criticality of inputs and Factors of differentiation; Exhibits115: Overview on factors of disruption; Exhibits116: Impact of key risks on business; Exhibits117: Vendors covered; Exhibits118: Matrix on vendor position and classification; Exhibits119: Advanced Enzyme Technologies Ltd. - Overview; Exhibits120: Advanced Enzyme Technologies Ltd. - Key offerings; Exhibits121: Amano Enzyme Inc. - Overview; Exhibits122: Amano Enzyme Inc. - Product / Service; Exhibits123: Amano Enzyme Inc. - Key offerings; Exhibits124: Amicogen Co., Ltd. - Overview; Exhibits125: Amicogen Co., Ltd. - Key offerings; Exhibits126: Antozyme Biotech Pvt. Ltd. - Overview; Exhibits127: Antozyme Biotech Pvt. Ltd. - Product / Service; Exhibits128: Antozyme Biotech Pvt. Ltd. - Key offerings; Exhibits129: BASF SE - Overview; Exhibits130: BASF SE - Business segments; Exhibits131: BASF SE - Key news; Exhibits132: BASF SE - Key offerings; Exhibits133: BASF SE - Segment focus; Exhibits134: BBI Solutions OEM Ltd. - Overview; Exhibits135: BBI Solutions OEM Ltd. - Product / Service; Exhibits136: BBI Solutions OEM Ltd. - Key offerings; Exhibits137: BRAIN Biotech AG - Overview; Exhibits138: BRAIN Biotech AG - Product / Service; Exhibits139: BRAIN Biotech AG - Key offerings; Exhibits140: Chr Hansen Holding AS - Overview; Exhibits141: Chr Hansen Holding AS - Business segments; Exhibits142: Chr Hansen Holding AS - Key news; Exhibits143: Chr Hansen Holding AS - Key offerings; Exhibits144: Chr Hansen Holding AS - Segment focus; Exhibits145: Codexis Inc. - Overview; Exhibits146: Codexis Inc. - Business segments; Exhibits147: Codexis Inc. - Key offerings; Exhibits148: Codexis Inc. - Segment focus; Exhibits149: Enzyme Development Corp. - Overview; Exhibits150: Enzyme Development Corp. - Product / Service; Exhibits151: Enzyme Development Corp. - Key offerings; Exhibits152: F. Hoffmann La Roche Ltd. - Overview; Exhibits153: F. Hoffmann La Roche Ltd. - Business segments; Exhibits154: F. Hoffmann La Roche Ltd. - Key news; Exhibits155: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits156: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits157: Koninklijke DSM NV - Overview; Exhibits158: Koninklijke DSM NV - Business segments; Exhibits159: Koninklijke DSM NV - Key news; Exhibits160: Koninklijke DSM NV - Key offerings; Exhibits161: Koninklijke DSM NV - Segment focus; Exhibits162: Maravai LifeSciences Holdings Inc. - Overview; Exhibits163: Maravai LifeSciences Holdings Inc. - Business segments; Exhibits164: Maravai LifeSciences Holdings Inc. - Key offerings; Exhibits165: Maravai LifeSciences Holdings Inc. - Segment focus; Exhibits166: Novozymes AS - Overview; Exhibits167: Novozymes AS - Business segments; Exhibits168: Novozymes AS - Key news; Exhibits169: Novozymes AS - Key offerings; Exhibits170: Novozymes AS - Segment focus; Exhibits171: Sanofi SA - Overview; Exhibits172: Sanofi SA - Business segments; Exhibits173: Sanofi SA - Key news; Exhibits174: Sanofi SA - Key offerings; Exhibits175: Sanofi SA - Segment focus; Exhibits176: Inclusions checklist; Exhibits177: Exclusions checklist; Exhibits178: Currency conversion rates for US$; Exhibits179: Research methodology; Exhibits180: Validation techniques employed for market sizing; Exhibits181: Information sources; Exhibits182: List of abbreviations